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Identification of Genomic Aberrations by Array Comparative 
Genomic Hybridization in Patients with Aortic Dissections
Jong  Hui  Suh,  M.D.*,  Jeong-Seob  Yoon,  M.D.*,  Jong-Bum  Kwon,  M.D.**, 
Hwan  Wook  Kim,  M.D.***,  Young-Pil  Wang,  M.D.***
Background:  The aim of the present study was to identify chromosomal loci that contribute to the pathogenesis of 
aortic dissection (AD) in a Korean population using array comparative genomic hybridization (CGH) and to confirm 
the results using real-time polymerase chain reaction (PCR). Materials and Methods: Eighteen patients with ADs 
were enrolled in this study. Genomic DNA was extracted from individual blood samples, and array CGH analyses 
were performed. Four corresponding genes with obvious genomic changes were analyzed using real-time PCR in 
order to assess the level of genomic imbalance identified by array CGH. Results: Genomic gains were most fre-
quently detected at 8q24.3 (56%), followed by regions 7q35, 11q12.2, and 15q25.2 (50%). Genomic losses were 
most frequently observed at 4q35.2 (56%). Real-time PCR confirmed the results of the array CGH studies of the 
COL6A2, DGCR14, PCSK6, and SDHA  genes.  Conclusion: This is the first study to identify candidate regions by 
array CGH in patients with ADs. The identification of genes that may predispose an individual to AD may lead to 
a better understanding of the mechanism of AD formation. Further multicenter studies comparing cohorts of patients 
of different ethnicities are warranted.
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INTRODUCTION
Aortic  dissection  (AD)  is  an  uncommon  but  highly  lethal 
disease  that  leads  to  the  gradual  deterioration  of  the  mechan-
ical  properties  of  the  aortic  wall.  It  is  caused  by  weak  aortic 
structure,  incompetent  repair  mechanisms  and  powerful  de-
structive  forces.  Although  genetic  factors  may  play  an  im-
portant  role  in  the  pathogenesis  of  AD  [1-3],  studies  inves-
tigating the genetic determinants of AD have been superficial, 
and reports of genetic risk factors for AD in Koreans are ex-
tremely  rare. 
　Several  chromosomal  loci  with  evidence  of  linkage  were 
found  in  studies  of  thoracic  aor t i c  d i s e a s e s  [ 4 - 6 ] ,  b u t  t h e  
mode  of  genetic  transmission  for  AD  remains  uncertain.  The 
identification  of  genetic  markers  associated  with  an  increased 
risk  of  AD  formation  and  growth  will  improve  the  treatment 
outcomes  of  patients  with  AD.
    Array  Comparative  Genomic  Hybridization  (CGH)  is  a Jong Hui Suh, et al
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Table 1. Demographic characteristics of the 18 subjects
Characteristic n
No.  of  patients 18
Sex,  female/male 8/10
Age,  yr 54.17±11.76
Operative  therapy 14
Conservative  therapy   4
DeBakey  classification
  T y p e  I    5
  T y p e  I I   1 0
  T y p e  I I I    3
Combined  diseases
  C o r o n a r y  a r t e r y  d i s e a s e  5
  A t h e r o s c l e r o s i s  4
    Bicuspid  aortic  valve   2
    Hypertension 15
  H y p e r l i p i d e m i a  2
    Diabetes  mellitus   2
　COPD   0
　Current  smoking   5
　Peripheral  vascular  disease   0
  S t r o k e  0
Familial  history  of  aortic  disease   0
COPD=Chronic  obstructive  pulmonary  disease.
powerful  technique,  allowing  the  simultaneous  quantitative 
analysis of entire genomes, including a higher resolution, more 
dynamic  range,  direct  mapping  of  aberrations  to  genomic  se-
quences,  and  higher  throughput  [7,8].  Therefore,  array  CGH 
has  been  used  to  detect  chromosomal  aberrations  in  mental 
retardation,  epilepsy, and schizophrenia  [9-12].  Real-time  pol-
ymerase  chain  reaction  (PCR)  has  been  used  to  empirically 
confirm the results of array CGH [13,14]. Moreover, quantita-
tive  real-time  PCR  has  great  advantages  in  measuring  DNA 
copy-number  changes  owing  to  the  economy,  simplicity,  and 
flexibility  of  the  technique  [15]. 
　The aim of the present study was to identify possible chro-
mosomal  loci  associated  with  the  pathogenesis  of  AD  in 
Koreans using array CGH and to confirm the results with re-
al-time  PCR.
MATERIALS AND METHODS
1) Patient population 
    A  total  of  18  patients  with  ADs  were  recruited  from  the 
single  hospital.  The  mean  age  of  the  patients  was  54.17 
years,  ranging  from  41  to  77  years.  The  demographic  data 
and  range  of  aortic  pathologic  disease  are  summarized  in 
Table  1.  Genomic  DNA  was  extracted  from  individual  blood 
samples  using  the  Puregene  DNA  isolation  kit  (Qiagen, 
Hilden, Germany). Reference DNA was pooled from ten gen-
der-matched (male), normal, healthy control subjects. Approval 
was  obtained  from  the  institutional  review  board  of  the 
College  of  Medicine  of  our  university,  and  informed  consent 
was  provided  according  to  the  Declaration  of  Helsinki. 
2) Array-CGH analysis 
    Array-CGH  analyses  were  conducted  on  18  individual 
samples.  Array  CGH  was  performed  as  described  previously 
[16]  using  a  commercial  MACArray
TM-Karyo  4K  BAC-chip 
(Macrogen,  Seoul,  Korea)  with  4,030  bacterial  artificial  chro-
mosome  (BAC)  clones  duplicating  the  whole  human  genome 
with  a  resolution  of  1  Mbp.  DNA  was  labeled  using  the 
BioPrime  labeling  kit  (Invitrogen,  Carlsbad,  CA).  Each  DNA 
(target  and  reference  DNA)  sample  (500∼700  ng)  with  ran-
dom  primers  was  boiled  at  98∼100
oC  for  5  min  for  denatu-
ration and then cooled on ice for 5 min. The denatured DNA 
was  differentially  labeled  with  3μL  of  1  mM  Cy3-dCTP 
(references  DNA),  Cy5-dCTP  (Target  DNA),  respectively 
(PerkinElmer,  Boston,  MA),  and  1μL  Klenow  fragments 
were  added  to  the  mixture  (Invitrogen,  Carlsbad,  CA).  DNA 
was  incubated  at  37
oC  overnight  for  labeling.  Subsequently, 
unincorporated  nucleotides  were  removed  using  MicroSpin 
G-50  columns  (Amersham  Biosciences,  Buckinghamshire, 
England). Cy3 and Cy5 labeled DNA (Target DNA and refer-
ence  DNA,  repectively)  was  mixed  with  50μg  of  human 
Cot-1  DNA  for  blocking  of  repeat  sequences.  After  purifica-
tion, the mixture was resolved in hybridization buffer contain-
ing  yeast  tRNA  for  blocking  binding  of  non-specific 
nucleotides.  After the  chips  were  in  hybridization  buffer with 
salmon  sperm  DNA  for  1  h,  the  chips  were  hybridized  with 
the  purification  mixture.  Then  they  were  incubated  for  72  h 
in  the  37
oC  hybridization  chamber  (BioMicro  Systems,  Salt 
Lake  City,  UT).  After  hybridization  was  complete,  the  array 
chips  were  washed  and  dried  and  then  the  arrays  were  scan-
ned  with  a  Genepix
Ⓡ  (Axon  Instruments,  Foster  City,  CA).
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Table 2. Recurrent Gains/Losses in aortic dissecting aneurysms (＞30 frequencies) (UCSC genome browser: May 2004)
Chromosomal 
region
Frequency 
(%)
Bac_start 
(bp)
Bac_end 
(bp)
Size 
(bp)
Contained  genes
Gains
1p11.2 6  (33%) 120390109 120485103 94994 NOTCH2
1q23.1 6  (33%) 155045002 155148010 103008 SH2D2A,  NTRK1,  INSRR
2p13.1 8  (44%) 74539520 74620052 80532 WBP1,  MRPL53,  LBX2,  PCGF1,  TLX2,  DQX1,  AUP1, 
  HTRA2,  LOXL3
2q31.1 6  (33%) 177310814 177395162 84348 FUCA1P
2q37.3 7  (39%) 240550837 240713841 163004 NDUFA10,  OR6B2,  OR6B3,  OR5S1P
3q21.3 6  (33%) 131099654 131218467 118813 TRH
4q13.3 8  (44%) 74536267 74654547 118280 AFP,  AFM
4q24 6  (33%) 105045356 105165560 120204
5p15.33 6  (33%) 203859 298137 94278 SDHA*
5p15.33 6  (33%) 557250 688780 131530 SLC9A3,  CEP72
6p12.2 6  (33%) 51985699 52087584 101885 PKHD1
7p14.3 7  (39%) 33392813 33486178 93365
7q11.23 7  (39%) 74705985 74764828 58843
7q11.23 8  (44%) 72089609 74747885 2658276 FKBP6,  NSUN5,  TRIM50,  FZD9,  BAZ1B,  BCL7B,  TBL2, 
  MLXIPL,  VPS37D,  WBSCR18,  STX1A,  ABHD11,  CLDN3, 
 C L D N 4 ,  W B S C R 2 7 ,  E L N ,  L I M K 1 ,  W B S C R 1 ,  L A T 2 ,  R F C 2 ,  
  CYLN2,  GTF2IRD1,  WBSCR23,  GTF2I,  PMS2L5, 
  WBSCR16,  NCF1,  GTF2IP1
7q35 9  (50%) 143557352 143585922 28570 OR2A42,  OR2A9P
8p21.2 6  (33%) 23582247 23671417 89170 NKX3-1
8p22 6  (33%) 18268730 18357165 88435 AACP,  NAT2
8p23.3 6  (33%) 649638 867290 217652 ERICH1,  C8orf68
8q13.2 6  (33%) 68343074 68444177 101103 ARFGEF1
8q24.3 10  (56%) 145298570 145384455 85885
10p15.3 6  (33%) 795549 881206 85657 LARP5
10q11.23 7  (39%) 52453706 52563182 109476 PRKG1
10q22.3 6  (33%) 79941269 80019660 78391
10q23.1 6  (33%) 86354131 86459920 105789
10q26.3 6  (33%) 134654530 134754530 100000 GPR123
11q12.2 9  (50%) 60669725 60731709 61984 VPS37C
3) Data analysis 
    The scanned images were analyzed to determine Cy3：Cy5 
ratios  for  each  array  element  using  MAC  Viewer
TM  v1.6.3 
software  (Macrogen,  Seoul,  Korea).  Data  are  presented  as 
log2  (Cy3  intensity/Cy5  intensity  ratios)  plotted  against  the 
position  of  clones  within  the  particular  chromosome  in  the 
current version of the genome. Ratios were normalized by us-
ing the median of fluorescence ratios computed as log2 values 
from  the  housekeeping  DNA  control  fragments  linearly  dis-
tributed  across  the  genome.  Measurements  flagged  as  un-
reliable  by  MAC  Viewer
TM  v1.6.3  were  excluded  from  sub-
sequent analyses. The threshold corresponds to 2 standard de-
viation  (SD)  values  from  the  mean.  The  information  on  each 
individual  clone  was  obtained  from  the  UCSC  Genome 
Bioinformatics database (May 2004 freeze, http://genome.ucsc. 
edu).  Then  log2  ratios  of  chromosomal  aberration  regions 
were  identified  via  t  test  analysis  using  the  Sigma  Plot 
program.  All  chromosome  regions  indicated  as  aberrant  in 
Table  2  were  calculated  via  t  test  analysis.
4) Quantitative real-time PCR 
    To  validate  genomic  imbalances  identified  by  array  CGH 
in this study, four genes with obvious genomic changes were Jong Hui Suh, et al
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Table 2. Continued
Chromosomal 
region
Frequency 
(%)
Bac_start 
(bp)
Bac_end 
(bp)
Size 
(bp)
Contained  genes
12p13.33 7  (39%) 183679 257363 73684 SLC6A12,  SLC6A13
12q13.13 6  (33%) 52345803 52436777 90974 ATP5G2,  CALCOCO1
13q33.3 6  (33%) 107569780 107652035 82255
14q24.2 6  (33%) 71175267 71266409 91142 SIPA1L1
14q32.33 7  (39%) 105541523 105648959 107436
15q25.2 9  (50%) 80539371 80776796 237425 RPS17
15q26.3 6  (33%) 99653473 99758817 105344 PCSK6*
17q12 6  (33%) 31081633 31171045 89412 RASL10B,  GAS2L2,  C17orf50,  MMP28,  TAF15
17q21.31 7  (39%) 39133290 39273024 139734 SOST,  DUSP3,  MPP3
17q25.3 6  (33%) 77755881 77849251 93370 SLC16A3,  CSNK1D
19p13.11 8  (44%) 17691080 17784835 93755 BPY2IP1,  FCHO1,  B3GNT3
19q13.43 6  (33%) 63514606 63629648 115042 HKR2,  A1BG,  ZNF497,  RPS5,  ZNF584
21q22.11 6  (33%) 31352497 31450699 98202 UBE3AP2,  TIAM1
21q22.3 7  (39%) 46373142 46463667 90525 COL6A2*,  FTCD,  C21orf56,  LSS
Losses
4q35.2 10  (56%) 190963818 191006683 42865
7q22.1 7  (39%) 100407386 100480418 73032 MUC12,  MUC17
10q26.3 7  (39%) 134755203 134904547 149344 GPR123,  KNDC1,  UTF1,  VENTX
14q32.33 8  (44%) 105821330 105907464 86134
15q11.2 8  (44%) 19958100 20053879 95779 VSIG6
16p12.3 6  (33%) 16274784 16391850 117066 NOMO3,  PKD1P1,  PKD1P2
16p13.11 7  (39%) 14873336 14958740 85404 NOMO1,  PKD1P3,  NPIP
22q11.21 7  (39%) 17158480 18962782 1804302 GGT2,  DGCR6,  PRODH,  DGCR5,  DGCR2,  TSSK7P, 
  DGCR13,  TSSK2,  DGCR14*,  GSCL,  SLC25A1,  CLTCL1, 
  HIRA,  MRPL40,  UFD1L,  CDC45L,  CLDN5,  SEPT5,  GP1BB, 
  TBX1,  GNB1L,  TXNRD2,  COMT,  ARVCF,  C22orf25, 
  DGCR8,  RANBP1,  ZDHHC8,  RTN4R,  DGCR6L
*=Verified  by  real-time  PCR.
analyzed  using  real-time  PCR.  For  relative  quantification,  the 
reactions were performed in a total volume of 50μL, includ-
ing  25μL  of  2×  IQ
TM S Y B R
Ⓡ  green  supermix  (Bio-Rad, 
Hercules,  CA),  10  ng  of  DNA,  and  10  pmol  of  each  primer. 
Forty  cycles  of  amplification,  data  acquisition,  and  data  anal-
ysis  were  performed  in  an  iCycler  (Bio-Rad,  Hercules,  CA). 
Primers  for  four  genes  (COL6A2,  DGCR14,  PCSK6,  and 
SDHA) were selected and the position of each clone was ob-
tained  from  the  UCSC  genome  database  (May  2004).  The 
primer  sequences  used  were  as  follows:  COL6A2,  forward, 
5'-TCCATGTCTCAAGCGTTCTG-3';  reverse,  5'-TGGGTT-
CTGCCCTATGACTC-3';  DGCR14,  forward,  5'-GACAGT-
TCAGCAGGCTTTCC-3';  reverse,  5'-TGATCTTGGCTCAC-
TGCAAC-3';  PCSK6,  forward,  5'-GGCAACAAAAGAAA-
GCAAGC-3';  reverse,  5'-TCTCAACAGCTGGGAGAGGT-3'; 
SDHA,  forward,  5’-CTGAGTGATGCCCTGCAGTA-3’;  re-
verse,  5'-TTCCACGAGCAGAGGAAACT-3'.  All  real-time 
PCR  procedures  were  performed  three  times  and  the  normal 
control  was  different  from  each  experiment  (all  three  normal 
samples).  The  relative  genomic  copy  number  was  calculated 
using the comparative CT method [17]. CT for each gene was 
determined  using  thermocycler  software,  and  the  average  of 
three independent experiments was calculated. The copy num-
ber  of  the  target  gene  was  normalized  to  an  endogenous  ref-
erence,  GAPDH,  which  showed  no  significant  copy  number 
change  in  each  genome  [18].  The  fold  change  from  normal 
samples was set at 1-fold and the ratio of the normalized fold 
change  in  TAD  compared  to  that  of  control  samples  was 
calculated.Genomic Aberrations in Aortic Dissections 
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Table 3. Examples of t test analysis in specific alterative regions
Chromosome 
region
Log2 r a t i o  
means±SD
T  value p-value
7q35 0.43±0.12 −11.06 6.6E-09
8q24.3 0.35±0.13   −8.40 1.21E-07
11q12.2 0.38±0.13   −8.78   1.64E-07
15q25.2 0.28±0.06 −13.54 4E-10
4q35.2 −0.63±0.34 5.88 1.45E-05
RESULTS
1) Pattern of aberration in individual chromosomal 
region
    Chromosomal copy-number changes were detected by array 
CGH in blood samples obtained from AD patients. The iden-
tified  regions  of  genomic  aberrations,  ranging  from  6  in  18 
samples (33% frequency of chromosomal gain and loss) to 10 
in  18  samples  (56%  frequency  of  chromosomal  gain  at  8q 
and  loss  at  4q)  (Table  2).  Overall,  the  individual  chromoso-
mal aberration pattern was not random and tended to be con-
sistent, showing DNA gains at 1p, 1q, 2p, 2q, 3q, 4q, 5p, 6p, 
7p, 7q,  8p, 8q, 10p, 10q, 11q, 12p, 12q, 13q, 14q, 15q, 17q, 
19p, 19q and 21q, and DNA losses at 4q, 7q, 10q, 14q, 15q, 
16p  and  22q.  Chromosomal  copy  number  gains  were  ob-
served  more  frequently  than  copy  number  losses.  The  most 
frequently  detected  gains  were  at  8q24.3  (56%).  DNA  gains 
were  also  frequently  observed  at  7q35,  11q12.2  and  15q25.2 
in  9  samples  (50%),  and  in  2p13.1,  4q13.3,  7q11.23  and 
19p13.11 in 8 samples (44%). Regions with a 39% frequency 
of  gains  were  2q37.3,  7p14.3,  7q11.23,  10q11.23,  12p13.33, 
14q32.33,  17q21.31  and  21q22.3.  Other  regions  with  33% 
frequency  of  DNA  gains  included  1p11.2,  1q23.1,  2q31.1, 
3q21.3, 4q24, 5p15.33,  6p12.2, 8p21.2, 8p22, 8p23.3, 8q13.2, 
10p15.3,  10q22.3,  10q23.1,  10q26.3,  12q13.13,  13q33.3, 
14q24.2,  15q26.3,  17q12,  17q25.3,  19q13.43  and  21q22.11. 
Genomic  losses  were  most  frequently  observed  in  4q35.2 
( 56% ).  Regions w ith 44 % f req uency  of  lo sses w ere 1 4q3 2.3 3 
and 15q11.2. Other regions with 33∼39% frequency of DNA 
loss  included  7q22.1,  10q26.3,  16p12.3,  16p13.11,  and 
22q11.21  (Table  2). 
　T o  a t t e m p t  t o  c o r r e l a t e  a  d i a g n o s i s  w i t h  a  s p e c i f i c  r e g i o n ,  
we applied statistics for each potential loci. All aberrant chro-
mosomal  locations  (＞30%)  detected  in  array  CGH  (Table  2) 
were selected in t test analysis. Although all 48 regions were 
calculated,  only  t  test  analysis  of  five  regions  is  shown  in 
Table  3.  Because  a  high  association  was  detected  in  all  re-
gions,  examples  which  indicated  higher  p-value  (＞50%  fre-
quency)  are  shown  in  the  Tables
2) Real-time PCR
　Four  genes  with  obvious  genomic  changes  were  analyzed 
using  real-time  PCR  in  order  to  assess  the  level  of  genomic 
imbalance identified by array CGH in this study. Of the more 
than 30% frequency clones, those considered to have vascular 
related  aberrations  in  the  chromosome  were  selected  for  re-
al-time  PCR.  We  evaluated  the  change  in  fold  difference  in 
samples  from  normal  and  AD  patients.  Fig.  1  shows  the  re-
gions  of  chromosomal  aberration  in  the  four  genes.  Gains 
were  seen  in  5p15.33,  15q26.3,  and  21q22.3,  which  contain 
the SDHA, PCSK6, and COL6A2 gen es (A ,  B, and  C),  w hile 
a loss was observed at 22q11.21, which contains the DGCR14 
genes  (D).  The  fold  difference  obtained  from  the  real-time 
PCR  was  in  accordance  with  the  array  CGH  results  and  the 
p-values of all samples was ＜0.05. The gain regions (A∼C; 
COL6A2,  PCSK6,  and  SDHA)  i n  t h e  r e s u l t s  f r o m  t h e  r e -
al-time  PCR  were  equal  to  all  of  the  gain  regions  in  the  ar-
ray  CGH.  The  relative  fold  decreases  in  DGCR14  (D)  were 
reflected  similarly. 
DISCUSSION
    Aortic  dissection  is  a  life-threatening  disease  that  develops 
without  warning.  Despite  significant  advances  in  diagnostic 
and  therapeutic  techniques,  the  overall  in-hospital  mortality 
was  27.4%  according  to  the  international  registry  of  aortic 
dissection [19]. It occurs in 2∼9% of the population over 65 
years old, and the prevalence may be increasing [20]. Modern 
diagnostic  methods,  such  as  computed  or  magnetic  resonance 
tomography, are able to show an aortic wall hematoma at the 
acute  onset  of  the  disease.  This  hematoma  will  develop  into 
an  aortic  wall dissection  over time [6].  Early recognition  and 
management  are  crucial,  and  it  is  therefore  important  to  be 
able  to  rapidly  identify  aortic  dissection,  initiate  supportive 
therapy,  and  refer  patients  to  appropriate  specialty  care  [2].Jong Hui Suh, et al
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Fig. 1. Relative fold differences selected from 4 genes in which the most frequent gains and losses detected were in the 5p, 15q, 21q, 
and 22q regions. Each sample is depicted (x axis), and the fold difference of the N-value was delineated in real-time PCR (y axis).  A 
threshold level of 2 indicates significant DNA gain (A∼C), and 0.5 indicates significant DNA loss (D). At the chromosomal 21q22.3 loca-
tion,  COL6A2  (A), the fold change of the sample was 2.25- to 3.14-fold (seven samples) versus 1-fold for the reference sample. The fold 
difference for the SDHA  (B) was 2.4- to 4.57-fold (six samples). For the PCSK6  (C), in the chromosomal 15q26.3 region, the fold change 
of the sample was 2.11- to 4.76-fold (six samples) with a gain at the location. Finally, DGCR14  (D) had a 0.08∼0.4-fold change (seven 
samples) with a loss at the location (p＜0.05).
　Current  research  is  aimed  at  determining  the  phenotypic 
consequences  of  specific  copy  number  abnormalities  in  pa-
tients with ADs [21]. Cytogenetic analyses have revealed that 
numerous  somatic  genetic  changes  in  the  pathogenesis  of  hu-
man  diseases  are  involved  in  region-specific  gains  or  losses 
of  DNA  copy  number;  however,  such  changes  have  not  yet 
been  reported  in  most  ADs.  Including  classical  cytogenetics, 
fluorescence in situ hybridization (FISH), Southern blot analy-
sis, quantitative PCR based assays, and CGH have been used 
to  detect  copy  number  changes  in  human  diseases,  but  these 
techniques  have  several  limitations  [22].  Therefore,  we  at-
tempted  to  use  array  CGH.  Unlike  chromosomal  CGH,  array 
CGH highly improves resolution and provides quantitative in-
formation  of  the  level  of  chromosomal  gain  or  loss  [16,23]. 
BAC  array  CGH  has  been  used  in  several  diseases  but  has 
n o t  b e e n  a p p l i e d  t o  A D s .  
　In this report, the DNA copy number alterations frequently 
i d e n t i f i e d  i n  1 8  p a t i e n t s  w i t h  A D  w e r e  a n a l y z e d  u s i n g  a r r a y  
based CGH. Many regions throughout the entire genome were 
altered.  The  DNA  copy  number  alterations  observed  in  the Genomic Aberrations in Aortic Dissections 
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ADs were not random; they involved particular regions of the 
genome  and  most  usually  involved  parts  of  or  the  entire 
DNA.  DNA  gains  were  found  in  regions  1p,  1q,  2p,  2q,  3q, 
4q, 5p, 6p 7p, 7q, 8p, 8q, 10p, 10q, 11q, 12p, 12q, 13q, 14q, 
15q,  17q,  19p,  and  21q,  and  losses  were  found  in  4q,  7q, 
10q,  14q,  15q,  16p,  and  22q  (Table  2).  DNA  gains  were 
more  frequently  observed  than  DNA  losses. 
　Real-time  PCR  can  be  used  to  validate  and  quantify  the 
genomic  changes  identified  by B A C  a r r a y  C G H  [ 1 7 ] .  O f  t h e  
more  than  30%  frequency  clones  in array CGH  results,  those 
considered to have vascular related aberrations in the chromo-
some  were  selected  for  real-time  PCR.  Frequently,  gains  of 
chromosomal DNA at COL6A2 were detected by CGH in pa-
tients  with  ADs.  The  collagen,  type  VI,  alpha-2  (COL6A2) 
gene encodes 1 of the 3 subunits that comprise the full colla-
gen  VI  protein.  Collagen  VI  is  expressed  in  developing  hu-
man  hearts  [24].  The  finding  that  collagen  VI  is  a  structural 
protein supports that collagen VI is a candidate gene involved 
in  the  development  of  congenital  heart  disease  in  Down 
syndrome.  The  most  frequent  locus  alteration  was  a  gain  at 
the  15q26.3  region  containing  the  PCSK6  gene.  PCSK6 
(PACE4)  is  expressed  at  high  levels  in  the  anterior  pituitary, 
central  nervous  system,  the  developing  olfactory  bulb,  heart, 
and  liver  [25].  Moreover,  SDHA  is  Complex  II  of  the  mi-
tochondrial  respiratory  chain,  also  known  as  succinate  de-
hydrogenase  or  succinate  ubiquinone  oxidoreductase,  and  it 
consists  of  four  nuclear-encoded  polypeptides.  The  specific 
function of this gene has not yet been determined. Bourgeron 
et al. identified a homozygous mutation in the SDHA gene in 
two  siblings  with  a  mitochondrial  complex  II  deficiency  pre-
senting as Leigh’s syndrome. Their study results demonstrated 
that  the  flavoprotein  subunit  gene  is  duplicated  in  the  human 
genome and located  on chromosome  5p15 [26]. Chromosome 
arm 22q, which includes the COMT and DGCR14 genes, was 
frequently  under-represented.  Chromosome  22q11.21  includes 
the  catechol  O-methyltransferase  (COMT)  gene,  and  its  dele-
tion  syndrome  is  a  common  microdeletion  syndrome  asso-
ciated  with a  markedly elevated  risk of  several diseases  [27]. 
In  addition  to  this  region,  DiGeorge  syndrome  critical  region 
gene 14 (DGCR14) has been associated with an elevated risk 
of  several  diseases.  A  group  of  developmental  disorders,  in-
cluding  DiGeorge  syndrome  (DGS),  velocardiofacial  syn-
drome  (VCFS),  conotruncal  anomaly  face  syndrome,  and 
some  familial  or  sporadic  conotruncal  cardiac  defects  have 
been associated with  microdeletion of 22q11.2 [28].  The four 
altered regions (5p15.33, 15q26.3, 21q22.3 and 22q11.21) that 
showed  frequent  genomic  alteration  were  confirmed  by  re-
al-time  PCR.
　In summary, array based CGH analysis of 18 patients with 
AD  showed  that  DNA  copy  number  alterations  are  common 
in  AD.  Real-time  PCR  confirmed  that  array  CGH  properly 
detected  gains  in  AD  related  genes.  Aortic  dissection  is  be-
lieved to develop through a chronic degeneration of the aortic 
wall  associated  with  aging,  atherosclerosis,  or  hypertension. 
But  its  etiology  remains  unresolved  [20].  In  this  study,  we 
were  able  to  delineate  discrete  regions  of  DNA  copy  number 
alterations  in  several  regions  of  the  chromosomes  that  are 
likely  to  harbor  some  relevant  genes. 
CONCLUSION
　These data support the utility of array CGH for the identi-
fication  of  genomic  alterations  in  AD.  Although  our  results 
suggest  a  new  aspect  of  genomic  alteration  in  patients  with 
ADs,  our  study  was  limited  by  a  small  sample  number  (n= 
18)  and  the  fact  that  it  only  included  individuals  of  Korean 
descent. Therefore, further studies should be carried out using 
CGH  techniques  to  validate  our  results.  Information  on  chro-
mosomal  variability  can  be  generated  by  comparing  the  re-
sults  of  array  CGH  with  information  from  the  Human 
Structural  Variation  Database  and  increasing  patient  numbers. 
　This study is the first to use array CGH to search for can-
didate regions in Korean aortic dissection patients, these find-
ings might contribute to the understanding of important chro-
mosomal  regions  and  the  identification  of  candidate  genes, 
and  may  be  used  to  investigate  the  pathogenesis  of  aortic 
dissections. 
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